BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20462933)

  • 1. Interaction between 5 genetic variants and allergy in glioma risk.
    Schoemaker MJ; Robertson L; Wigertz A; Jones ME; Hosking FJ; Feychting M; Lönn S; McKinney PA; Hepworth SJ; Muir KR; Auvinen A; Salminen T; Kiuru A; Johansen C; Houlston RS; Swerdlow AJ
    Am J Epidemiol; 2010 Jun; 171(11):1165-73. PubMed ID: 20462933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.
    Viana-Pereira M; Moreno DA; Linhares P; Amorim J; Nabiço R; Costa S; Vaz R; Reis RM
    Mol Biol Rep; 2020 Feb; 47(2):877-886. PubMed ID: 31721021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study identifies five susceptibility loci for glioma.
    Shete S; Hosking FJ; Robertson LB; Dobbins SE; Sanson M; Malmer B; Simon M; Marie Y; Boisselier B; Delattre JY; Hoang-Xuan K; El Hallani S; Idbaih A; Zelenika D; Andersson U; Henriksson R; Bergenheim AT; Feychting M; Lönn S; Ahlbom A; Schramm J; Linnebank M; Hemminki K; Kumar R; Hepworth SJ; Price A; Armstrong G; Liu Y; Gu X; Yu R; Lau C; Schoemaker M; Muir K; Swerdlow A; Lathrop M; Bondy M; Houlston RS
    Nat Genet; 2009 Aug; 41(8):899-904. PubMed ID: 19578367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic risk profiles identify different molecular etiologies for glioma.
    Simon M; Hosking FJ; Marie Y; Gousias K; Boisselier B; Carpentier C; Schramm J; Mokhtari K; Hoang-Xuan K; Idbaih A; Delattre JY; Lathrop M; Robertson LB; Houlston RS; Sanson M
    Clin Cancer Res; 2010 Nov; 16(21):5252-9. PubMed ID: 20847058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies.
    Di Stefano AL; Enciso-Mora V; Marie Y; Desestret V; Labussière M; Boisselier B; Mokhtari K; Idbaih A; Hoang-Xuan K; Delattre JY; Houlston RS; Sanson M
    Neuro Oncol; 2013 May; 15(5):542-7. PubMed ID: 23161787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
    Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
    J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking.
    Lachance DH; Yang P; Johnson DR; Decker PA; Kollmeyer TM; McCoy LS; Rice T; Xiao Y; Ali-Osman F; Wang F; Stoddard SM; Sprau DJ; Kosel ML; Wiencke JK; Wiemels JL; Patoka JS; Davis F; McCarthy B; Rynearson AL; Worra JB; Fridley BL; O'Neill BP; Buckner JC; Il'yasova D; Jenkins RB; Wrensch MR
    Am J Epidemiol; 2011 Sep; 174(5):574-81. PubMed ID: 21742680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk.
    Safaeian M; Rajaraman P; Hartge P; Yeager M; Linet M; Butler MA; Ruder AM; Purdue MP; Hsing A; Beane-Freeman L; Hoppin JA; Albanes D; Weinstein SJ; Inskip PD; Brenner A; Rothman N; Chatterjee N; Gillanders EM; Chanock SJ; Wang SS
    Cancer Causes Control; 2013 Oct; 24(10):1885-91. PubMed ID: 23903690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic causes of glioma: new leads in the labyrinth.
    Melin B
    Curr Opin Oncol; 2011 Nov; 23(6):643-7. PubMed ID: 21825990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk.
    Wu Q; Peng Y; Zhao X
    Mol Neurobiol; 2016 Sep; 53(7):4397-405. PubMed ID: 26243184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study.
    Melin B; Dahlin AM; Andersson U; Wang Z; Henriksson R; Hallmans G; Bondy ML; Johansen C; Feychting M; Ahlbom A; Kitahara CM; Wang SS; Ruder AM; Carreón T; Butler MA; Inskip PD; Purdue M; Hsing AW; Mechanic L; Gillanders E; Yeager M; Linet M; Chanock SJ; Hartge P; Rajaraman P
    Int J Cancer; 2013 May; 132(10):2464-8. PubMed ID: 23115063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic conditions and brain tumor risk.
    Wigertz A; Lönn S; Schwartzbaum J; Hall P; Auvinen A; Christensen HC; Johansen C; Klaeboe L; Salminen T; Schoemaker MJ; Swerdlow AJ; Tynes T; Feychting M
    Am J Epidemiol; 2007 Oct; 166(8):941-50. PubMed ID: 17646205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into susceptibility to glioma.
    Liu Y; Shete S; Hosking FJ; Robertson LB; Bondy ML; Houlston RS
    Arch Neurol; 2010 Mar; 67(3):275-8. PubMed ID: 20212223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population.
    Chen H; Chen Y; Zhao Y; Fan W; Zhou K; Liu Y; Zhou L; Mao Y; Wei Q; Xu J; Lu D
    Am J Epidemiol; 2011 Apr; 173(8):915-22. PubMed ID: 21350045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.
    Walsh KM; Rice T; Decker PA; Kosel ML; Kollmeyer T; Hansen HM; Zheng S; McCoy LS; Bracci PM; Anderson E; Hsuang G; Wiemels JL; Pico AR; Smirnov I; Molinaro AM; Tihan T; Berger MS; Chang SM; Prados MD; Lachance DH; Sicotte H; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR
    Neuro Oncol; 2013 Aug; 15(8):1041-7. PubMed ID: 23733245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity.
    Jenkins RB; Wrensch MR; Johnson D; Fridley BL; Decker PA; Xiao Y; Kollmeyer TM; Rynearson AL; Fink S; Rice T; McCoy LS; Halder C; Kosel ML; Giannini C; Tihan T; O'Neill BP; Lachance DH; Yang P; Wiemels J; Wiencke JK
    Cancer Genet; 2011 Jan; 204(1):13-8. PubMed ID: 21356187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic advances in glioma: susceptibility genes and networks.
    Liu Y; Shete S; Hosking F; Robertson L; Houlston R; Bondy M
    Curr Opin Genet Dev; 2010 Jun; 20(3):239-44. PubMed ID: 20211558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B and RTEL1 genes in glioma: a meta-analysis.
    Wu Y; Zhou J; Zhang J; Tang Z; Chen X; Huang L; Liu S; Chen H; Wang Y
    Front Oncol; 2023; 13():1180099. PubMed ID: 37746290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergy-related polymorphisms influence glioma status and serum IgE levels.
    Wiemels JL; Wiencke JK; Kelsey KT; Moghadassi M; Rice T; Urayama KY; Miike R; Wrensch M
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1229-35. PubMed ID: 17548690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26.
    Alpen K; Vajdic CM; MacInnis RJ; Milne RL; Koh ES; Hovey E; Harrup R; Bruinsma F; Nguyen TL; Li S; Joseph D; Benke G; Dugué PA; Southey MC; Giles GG; Rosenthal M; Drummond KJ; Nowak AK; Hopper JL; Kapuscinski M; Makalic E
    Neuro Oncol; 2023 Jul; 25(7):1355-1365. PubMed ID: 36541697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.